Thu, October 15, 2020

Geoff Meacham Maintained (BIIB) at Sell with Decreased Target to $235 on, Oct 15th, 2020

Geoff Meacham of B of A Securities, Maintained "Biogen Inc." (BIIB) at Sell with Decreased Target from $255 to $235 on, Oct 15th, 2020.

Geoff has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020
  • Carter Gould of "Barclays" Downgraded from Buy to Hold and Decreased Target to $280 on, Monday, June 22nd, 2020


These are the ratings of the 3 analyists that currently disagree with Geoff


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $355 on, Tuesday, October 13th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Decreased Target to $228 on, Friday, June 19th, 2020